Lexicon Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LXRX and other ETFs, options, and stocks.

About LXRX

Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain, and Sotagliflozin, a treatment for heart failure and type 1 diabetes. 

CEO
Michael Exton
CEOMichael Exton
Employees
103
Employees103
Headquarters
The Woodlands, Texas
HeadquartersThe Woodlands, Texas
Founded
1995
Founded1995
Employees
103
Employees103

LXRX Key Statistics

Market cap
332.28M
Market cap332.28M
Price-Earnings ratio
-1.78
Price-Earnings ratio-1.78
Dividend yield
Dividend yield
Average volume
6.16M
Average volume6.16M
High today
$0.9199
High today$0.9199
Low today
$0.8627
Low today$0.8627
Open price
$0.8627
Open price$0.8627
Volume
2.66M
Volume2.66M
52 Week high
$2.45
52 Week high$2.45
52 Week low
$0.2836
52 Week low$0.2836

LXRX News

TipRanks 6d
Lexicon Pharmaceuticals Granted Nasdaq Compliance Extension

Don’t Miss TipRanks’ Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights...

People also own

Based on the portfolios of people who own LXRX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.